Response to Existing Biochemical Autism Pathology Models

Model Clarification

Response to Existing Biochemical Autism Pathology Models

The distinction is not whether biochemical changes exist in autism. The distinction is how those changes are organized into a system-level cascade and what governs their behavior over time.

Existing Models

Recognize biochemical involvement

Many models examine metabolic, immune, mitochondrial, redox, and neurotransmitter pathways independently or in clusters. Each existing model has a unique focus.

What Determines Cascade Behavior

The cascade is not defined by mechanism alone. It is shaped by how regulatory systems are activated, how long they remain active, and how that activation interacts with temporal system domains.

Type of Activation

Situational, chronic, or genetically sustained activation.

Duration

Short-term versus prolonged activation determines system load and downstream impact.

Regulatory Systems

Immune, metabolic, nervous system, cellular repair, and genomic regulation.

Temporal Domains

Ultradian, circadian, developmental, and lifespan timing influence how changes accumulate.

Kitzerow's Specific Contribution

Kitzerow's contribution is a unified cascade model in which BH4 redistribution operates as the organizing mechanism and system behavior is determined by duration, type of activation, and timing across regulatory domains.

Biochemical Model Comparison

How Kitzerow’s Autism and the Comorbidities Theoretical Model Relates to Existing Biochemical Autism Models

These models do not operate from the same organizing logic. Kitzerow’s Autism and the Comorbidities Theoretical Model differs not by recognizing biochemistry, but by how the cascade is structured, centralized, and explained.

Amy Yasko

Organizing Logic

Organized around inherited polymorphisms affecting methylation, transsulfuration, detoxification, and related pathway checkpoints.

Primary Focus

How SNPs, toxins, and pathway inefficiencies alter biochemical throughput and create intervention points across interconnected pathways.

How Kitzerow’s Framework Differs

Kitzerow’s Autism and the Comorbidities Theoretical Model is not organized around pathway inefficiencies or SNP-driven checkpoints. It is organized around BH4 shunting as a constrained regulatory state, with methylation and transsulfuration changes interpreted as downstream effects within a coordinated cascade shaped by system activation and duration.